Astria Therapeutics, Inc. - Common Stock (ATXS)
7.5700
+0.0500 (0.66%)
Astri Therapeutics Inc is a biotechnology company focused on developing innovative therapies for rare and complex genetic diseases
The company leverages advanced scientific research to create targeted treatments that address the underlying causes of these disorders, with a commitment to improving patient outcomes. Through its dedicated team and state-of-the-art technologies, Astri Therapeutics aims to bring transformative therapies to market, thereby enhancing the quality of life for patients and their families affected by these challenging conditions.
Frequently Asked Questions
Is Astria Therapeutics, Inc. - Common Stock publicly traded?
Yes, Astria Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Astria Therapeutics, Inc. - Common Stock trade on?
Astria Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Astria Therapeutics, Inc. - Common Stock?
The ticker symbol for Astria Therapeutics, Inc. - Common Stock is ATXS on the Nasdaq Stock Market
What is the current price of Astria Therapeutics, Inc. - Common Stock?
The current price of Astria Therapeutics, Inc. - Common Stock is 7.570
When was Astria Therapeutics, Inc. - Common Stock last traded?
The last trade of Astria Therapeutics, Inc. - Common Stock was at 9:30 am EST on February 5th, 2025